Fouad Namouni
Director, Aprea Therapeutics, Inc.
Companies
- Vor Biopharma Inc.Board member May 2, 2024 to now1
- Blueprint Medicines CorpPresident Sep 4, 2020 to now2
- Aprea Therapeutics, Inc.Board member Jun 29, 2020 to Jul 1, 20213
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Blueprint Medicines Corp0 shares4Jul 17, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 17, 2025U 31,956 shares of Blueprint Medicines Corp4
- Jul 17, 2025Returned to company 83,281 shares of Blueprint Medicines Corp4
- Jul 17, 2025Granted 39,456 shares of Blueprint Medicines Corp4
- Mar 5, 2025Sold 6,489 shares at $88.80 of Blueprint Medicines Corp5
- Mar 1, 2025Granted 13,200 shares of Blueprint Medicines Corp6
- Oct 3, 2024Sold 3,633 shares at $89.32 of Blueprint Medicines Corp7
- Mar 7, 2024Sold 4,377 shares at $90.69 of Blueprint Medicines Corp8
- Mar 1, 2024Granted 15,000 shares of Blueprint Medicines Corp9
- Oct 4, 2023Sold 3,769 shares at $48.06 of Blueprint Medicines Corp10
- Mar 6, 2023Sold 63 shares at $44.36 of Blueprint Medicines Corp11
- Mar 6, 2023Sold 1,885 shares at $45.72 of Blueprint Medicines Corp11
- Mar 1, 2023Granted 15,000 shares of Blueprint Medicines Corp12
- Oct 4, 2022Sold 3,477 shares at $67.30 of Blueprint Medicines Corp13
- Mar 7, 2022Sold 1,047 shares at $56.19 of Blueprint Medicines Corp14
- Mar 1, 2022Granted 15,000 shares of Blueprint Medicines Corp15
- Oct 5, 2021Sold 3,241 shares at $98.18 of Blueprint Medicines Corp16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARVor Biopharma Inc., Board member
- 2SEC EDGARBlueprint Medicines Corp, President
- 3
- 4
- 5SEC EDGARForm 4 filed Mar 7, 2025
- 6SEC EDGARForm 4 filed Mar 4, 2025
- 7SEC EDGARForm 4 filed Oct 4, 2024
- 8SEC EDGARForm 4 filed Mar 11, 2024
- 9SEC EDGARForm 4 filed Mar 6, 2024
- 10SEC EDGARForm 4 filed Oct 5, 2023
- 11SEC EDGARForm 4 filed Mar 8, 2023
- 12SEC EDGARForm 4 filed Mar 3, 2023
- 13SEC EDGARForm 4 filed Oct 5, 2022
- 14SEC EDGARForm 4 filed Mar 8, 2022
- 15SEC EDGARForm 4 filed Mar 3, 2022
- 16SEC EDGARForm 4 filed Oct 7, 2021